Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Can We Stop Ordering Prostate-Specific Antigen Screening Tests?

Can We Stop Ordering Prostate-Specific Antigen Screening Tests? EDITORIAL LESS IS MORE Can We Stop Ordering Prostate-Specific Antigen Screening Tests? RUN THE SECOND LARGEST SAFETY-NET SYSTEM IN (doing what we believe even if the experts disagree) or a the United States. As is true of all safety-net sys- kind of arrogance (yes, the USPSTF of experts recom- tems in the United States, we have a finite bud- mended against this test, but I know better)? Or is it both? get; overwhelmingly, our patients are uninsured Because medical practice is generally viewed as an au- I or publicly insured, so we cannot raise our rates tonomous activity, almost any test that a physician orders to pay for emerging populations and treatments. Instead, from a standard laboratory is considered to fall within the I see our mission as trying to provide the best health care hard-to-pin-down “community standard” of practice. Com- we can for the available funding (highest value). pared with laboratory test ordering, medication ordering Few would disagree with the mission of providing the seems to be a tightly regulated activity. Even though we highest-value health care possible. Unfortunately, the con- know that US Food and Drug Administration (FDA)- sensus dissipates when a particular practice is targeted for http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Can We Stop Ordering Prostate-Specific Antigen Screening Tests?

Katz, Mitchell H.
JAMA Internal Medicine , Volume 173 (10) – May 27, 2013
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/can-we-stop-ordering-prostate-specific-antigen-screening-tests-pMAWtSL9n4

References (8)

Publisher
American Medical Association
Copyright
Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2013.1164
pmid
23588841
Publisher site
See Article on Publisher Site

Abstract

EDITORIAL LESS IS MORE Can We Stop Ordering Prostate-Specific Antigen Screening Tests? RUN THE SECOND LARGEST SAFETY-NET SYSTEM IN (doing what we believe even if the experts disagree) or a the United States. As is true of all safety-net sys- kind of arrogance (yes, the USPSTF of experts recom- tems in the United States, we have a finite bud- mended against this test, but I know better)? Or is it both? get; overwhelmingly, our patients are uninsured Because medical practice is generally viewed as an au- I or publicly insured, so we cannot raise our rates tonomous activity, almost any test that a physician orders to pay for emerging populations and treatments. Instead, from a standard laboratory is considered to fall within the I see our mission as trying to provide the best health care hard-to-pin-down “community standard” of practice. Com- we can for the available funding (highest value). pared with laboratory test ordering, medication ordering Few would disagree with the mission of providing the seems to be a tightly regulated activity. Even though we highest-value health care possible. Unfortunately, the con- know that US Food and Drug Administration (FDA)- sensus dissipates when a particular practice is targeted for

Journal

JAMA Internal Medicine – American Medical Association

Published: May 27, 2013

There are no references for this article.